Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

HeroMD The Hero Review 2026: Sildenafil and Tadalafil Combined in a Compounded Prescription - What Patients Should Know
Healthcare & PharmaceuticalAdvertorial

HeroMD The Hero Review 2026: Sildenafil and Tadalafil Combined in a Compounded Prescription - What Patients Should Know

February 18, 2026 10:30 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Concerns about men's vascular health and prescription treatment options should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you click on these links and initiate a consultation or make a purchase, a...

Read more
HeroMD Prime Review (2026): The Daily Tadalafil + Vardenafil Gum Explained
Healthcare & PharmaceuticalAdvertorial

HeroMD Prime Review (2026): The Daily Tadalafil + Vardenafil Gum Explained

February 18, 2026 10:30 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. HeroMD Prime is a compounded prescription medication that requires evaluation and approval by a licensed clinician and is not available without a prescription. Always consult a qualified healthcare professional before starting any new prescription treatment. This article contains affiliate links. If you click these links and complete a...

Read more
HeroMD Surge Review 2026: Compounded Sildenafil + Pycnogenol ODT - Is This Prescription Telehealth Service Legit?
Healthcare & PharmaceuticalAdvertorial

HeroMD Surge Review 2026: Compounded Sildenafil + Pycnogenol ODT - Is This Prescription Telehealth Service Legit?

February 18, 2026 10:30 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Men's health concerns - including conditions affecting vascular function - should be evaluated by qualified healthcare professionals. A commission may be earned if you purchase through links in this article, at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. Always consult a...

Read more
ReadyRx Sermorelin ODT Review (2026): Needle-Free Growth Hormone Support, Prescription Process, and What to Expect
Healthcare & PharmaceuticalAdvertorial

ReadyRx Sermorelin ODT Review (2026): Needle-Free Growth Hormone Support, Prescription Process, and What to Expect

February 18, 2026 10:15 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Prescription treatment requires evaluation by a licensed clinician. This contains affiliate links. A commission may be earned at no additional cost to you if you purchase through these links. ReadyRx Sermorelin ODT (2026) Telehealth Overview: Needle-Free, Prescription Sermorelin and What Patients Should Know If you're reading this in early 2026,...

Read more
ReadyRx MIC+B12 Review 2026: What the Ingredient Research and Subscription Terms Actually Say
Healthcare & PharmaceuticalAdvertorial

ReadyRx MIC+B12 Review 2026: What the Ingredient Research and Subscription Terms Actually Say

February 18, 2026 9:15 PM

Disclosure: This article contains affiliate links; a commission may be earned at no additional cost to you. Compensation may influence content priorities; however, we aim to present information accurately and to clearly attribute statements to the brand or to general medical references. This content is for informational purposes only and does not constitute medical advice. Prescription decisions must be made with a licensed clinician. ReadyRx...

Read more
ReadyRx NAD+ Nasal Spray Review 2026: Prescription Telehealth NAD+ Worth the Cost?
Healthcare & PharmaceuticalAdvertorial

ReadyRx NAD+ Nasal Spray Review 2026: Prescription Telehealth NAD+ Worth the Cost?

February 18, 2026 8:40 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. NAD+ nasal spray is a compounded prescription medication that requires evaluation by a licensed clinician. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This...

Read more
TRNR Signs Definitive Agreement to Acquire Ergatta, Increasing 2026 Pro Forma Revenue Guidance by 50% to More than $30m
Healthcare & PharmaceuticalMergers and Acquisitions

TRNR Signs Definitive Agreement to Acquire Ergatta, Increasing 2026 Pro Forma Revenue Guidance by 50% to More than $30m

February 18, 2026 11:30 AM

AUSTIN, TX and BROOKLYN, NY / ACCESS Newswire / February 18, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner of the Wattbike, FORME, and CLMBR connected fitness brands, today announced it has signed a definitive agreement to acquire Ergatta, Inc., the pioneer in game-based connected fitness. The parties signed a letter of intent on January 9, 2026, and have been working on the binding definitive agreement since...

Read more
CVS Health Announces $5 Million Scholarship Program To Support Future Pharmacists in Louisiana
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health Announces $5 Million Scholarship Program To Support Future Pharmacists in Louisiana

February 18, 2026 10:20 AM

Originally published on CVS Health Company News CVS Health® (NYSE:CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana. The initiative will provide financial assistance to students pursuing their Doctor of Pharmacy (PharmD) degree at either Xavier University of Louisiana or the University of Louisiana at Monroe. This initiative is part of CVS Health's broader...

Read more
Fortified Health Security Debuts Scalable TPRM Solution for Healthcare
Healthcare & PharmaceuticalCompany Update

Fortified Health Security Debuts Scalable TPRM Solution for Healthcare

February 18, 2026 10:00 AM

Fortified Health Security, five-time consecutive Best in KLAS winner and healthcare's cybersecurity partner, now offers clients a next-gen TPRM solution. TPRM now with VendorIQ is designed to help healthcare organizations manage third-party vendor risk in a way that drives real risk reduction at scale with greater speed, efficiency, and clarity. By embedding healthcare cybersecurity experts directly into procurement workflows and individually...

Read more
Ankle Injuries Among the Most Common Sports Injuries as Baseball Season Kicks Off
Healthcare & PharmaceuticalCompany Update

Ankle Injuries Among the Most Common Sports Injuries as Baseball Season Kicks Off

February 18, 2026 9:23 AM

Ankle & Foot Centers of America is encouraging patients not to ignore ankle pain this February. Whether caused by a sports injury, a fall, or everyday missteps, ankle injuries can lead to long-term complications if left untreated. As winter activities, travel, and new fitness routines increase at the start of the year, podiatrists are seeing a rise in ankle sprains, strains, and fractures. Seeking professional evaluation early can help reduce...

Read more
Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10
Healthcare & PharmaceuticalCompany Update

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

February 18, 2026 9:15 AM

Tivic (Nasdaq:TIVC), a late-stage immuno-therapeutics company, today announced that a second, follow-up meeting with the Biomedical Advanced Research and Development Authority (BARDA) has been scheduled for March 10, 2026, to continue discussions focused on clinical data and the potential for funding and, ultimately, stockpiling Entolimod™ for Acute Radiation Syndrome (ARS). On January 26, 2026, Tivic attended an initial TechWatch meeting with...

Read more
Jaguar Health Announces a Special One-time Stock Dividend
Healthcare & PharmaceuticalDividends

Jaguar Health Announces a Special One-time Stock Dividend

February 18, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a one-time special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock and certain outstanding warrants as of record on March 2, 2026. The Special Stock Dividend will consist of the Company's Series O Convertible Preferred Stock (the "Preferred Stock"). Only persons who own shares of the Company's...

Read more
FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether
Healthcare & PharmaceuticalCompany Update

FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether

February 18, 2026 9:00 AM

The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex™ Dynamic Sagittal Tether, a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression. Developed by Empirical Spine (San Carlos, CA) from foundational research at Stanford University, LimiFlex represents more than twenty years of refinement and clinical...

Read more
EDGE Surgical Announces $125,000 Distribution Agreement with Specialty Med-Surg Device
Healthcare & PharmaceuticalPartnerships

EDGE Surgical Announces $125,000 Distribution Agreement with Specialty Med-Surg Device

February 18, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, has announced a $125,000 agreement with Specialty Med-Surg Device to serve as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in the Detroit metro area. This relationship arrives at a critical time, driven by the growing demand for the Ortho EDG®. Med-Surg Device will distribute EDGE Surgical's innovative...

Read more
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
Healthcare & PharmaceuticalCompany Update

Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion

February 18, 2026 8:35 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's...

Read more
Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup

February 18, 2026 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has completed a strategic investment in a San Francisco-based mental health AI startup on the cusp of launching its service following successful beta testing....

Read more
AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market
Healthcare & PharmaceuticalProduct Announcements

AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market

February 18, 2026 7:00 AM

AQP ONE Inc., a U.S.-based health technology company founded by Vietnamese refugee entrepreneur, engineer, and University of Minnesota-trained chemist Tracy (Trang) Nguyen, today announced the launch of JBA AICare™, a physiological intelligence system designed to help individuals understand their health earlier and more continuously. The global wearable technology market is projected to exceed $100 billion in the coming years, fueled by advances...

Read more
Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Healthcare & PharmaceuticalCompany Update

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

February 18, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that, in response to a prior Refusal-to-File (RTF) letter, the Company engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and proposed a revised regulatory approach for its investigational seasonal influenza vaccine candidate, mRNA-1010. To advance the review, Moderna proposed a regulatory pathway based on age, seeking full approval for adults 50 to 64 years of age and...

Read more
Senzime Secures Credit Line Facility of 50 MSEK
Healthcare & PharmaceuticalRegulatory

Senzime Secures Credit Line Facility of 50 MSEK

February 18, 2026 2:50 AM

Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) announces that the company has secured a credit line facility of 50 MSEK. The credit facility has been issued at fair market terms by a group of existing shareholders including Crafoord and Segulah, as well DBT Capital, a part of Noba Bank Group. The credit facility of total 50 MSEK consists in part of a loan and in part of a revolving credit facility that can be called upon to cover peaks in working...

Read more
Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability
Healthcare & PharmaceuticalEarnings

Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability

February 18, 2026 2:45 AM

Senzime AB's (publ.) (STO:SEZI)(OTCQX:SNZZF) year-end report for January - December 2025 is now available on the company's website www.senzime.com. Financial summary October-December 2025 Net sales increased by 102 percent to MSEK 28.3 (14.0) Currency-adjusted net sales amounted to MSEK 31.5, an increase of 125 percent Gross margin before depreciation amounted to 25.1 percent (67.4) affected by currency effects, US tariffs and inventory...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?